SCHEMBL6555742

SCHEMBL6555742

COCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C=C/c1ccc(-c2nc3c(=O)n(C)c(=O)n(Cc4cccc(C#N)c4)c3[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 5/20 0.38
▸ ADORA3 P0DMS8 4/20 0.38
▸ DPP4 P27487 1/20 0.36
▸ GRIN1 Q05586 2/20 0.36
▸ GRIN2B Q13224 2/20 0.36
▸ POLB P06746 1/20 0.35
▸ ROCK2 O75116 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ ADORA2A P29274 2/20 0.33
▸ HDAC8 Q9BY41 2/20 0.33
▸ HDAC6 Q9UBN7 2/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ PARG Q86W56 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553631 0.92 ADORA2B (0.38) ADORA2BADORA3GRIN1GRIN2BKDM4E
SCHEMBL9157409 0.86 ADORA2B (0.50) ADORA2BADORA3DPP4GRIN1GRIN2B
SCHEMBL9157419 0.86 ADORA2B (0.50) ADORA2BADORA3DPP4GRIN1GRIN2B
SCHEMBL6554030 0.84 ADORA2B (0.43) ADORA2BADORA3GRIN1GRIN2BADORA2A
SCHEMBL6049595 0.83 ADORA2B (0.52) ADORA2BADORA3KDM4EALDH1A1ADORA2A
SCHEMBL6555320 0.82 ADORA2B (0.44) ADORA2BADORA3KDM4EADORA2AADORA1
SCHEMBL6553577 0.82 ADORA2B (0.42) ADORA2BADORA3ADORA2AADORA1
SCHEMBL17691164 0.80 ADORA2B (0.44) ADORA2BADORA3KDM4EALDH1A1ADORA2A
SCHEMBL6049598 0.80 ADORA2B (0.44) ADORA2BADORA3KDM4EALDH1A1ADORA2A
SCHEMBL6553692 0.80 ADORA2B (0.43) ADORA2BADORA3POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030032804-A1 Methods of treating periodontal disease SMITHKLINE BEECHAM CORPORATION 2003-02-13 — — US claimed
US-6770267-B2 Methods of treating periodontal disease SMITHKLINE BEECHAM CORPORATION 2004-08-03 — — US disclosed
EP-1104422-B1 PHENYL XANTHINE DERIVATIVES GLAXO GROUP LTD (GB) 2004-02-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032804-A1 Methods of treating periodontal disease HPGDS, SELP, ALPI ADORA2B 439/4885ADORA3 656/4885DPP4 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback